Atherosclerotic identification
First Claim
Patent Images
1. A method of identifying atherosclerotic plaque versus structurally viable tissue, said method including the steps of:
- emitting a beam of light at a single excitation wavelength of between 350 an 390 nm at a tissue;
detecting an quantifying the fluorescence emission spectrum of the emitted beam at critical points of optimum distinguishing emission from atherosclerotic plaque and structurally viable tissue; and
distinguishing the presence of atherosclerotic plaque from structurally viable tissue by the presence of absence of the quantity of intensity of emissions at the critical points of optimum distinguishing emission.
1 Assignment
0 Petitions
Accused Products
Abstract
A method of identifying atherosclerotic plaque versus structurally viable tissue includes the steps of emitting a fluorescent beam at a single excitation wavelength of between 350 and 390 nm at a tissue and detecting and quantifying the emission spectrum of the emitted beam at critical points chosen to optimize the difference between atherosclerotic plaque and structurally viable tissue. The presence of the atherosclerotic plaque is distinguished from structurally viable tissue by the presence or absence of the intensity of emissions at the critical points of optimum distinguishing wavelengths. 8
220 Citations
4 Claims
-
1. A method of identifying atherosclerotic plaque versus structurally viable tissue, said method including the steps of:
- emitting a beam of light at a single excitation wavelength of between 350 an 390 nm at a tissue;
detecting an quantifying the fluorescence emission spectrum of the emitted beam at critical points of optimum distinguishing emission from atherosclerotic plaque and structurally viable tissue; and
distinguishing the presence of atherosclerotic plaque from structurally viable tissue by the presence of absence of the quantity of intensity of emissions at the critical points of optimum distinguishing emission. - View Dependent Claims (2, 3, 4)
- emitting a beam of light at a single excitation wavelength of between 350 an 390 nm at a tissue;
Specification